Literature DB >> 215172

Efficacy of hypolipidemic treatment in inhibition of experimental atherosclerosis: the effect of nicotinic acid and related compounds.

M R Parwaresch, H Haacke, C Mäder.   

Abstract

The hypolipidemic and antiatherogenic effects of different nicotinic acid derivatives were studied. Five rabbit groups maintained on an atherogenic diet were given simultaneously various nicotinic acid derivatives (50 mg/kg body weight/day): nicotinic acid, Xantinol-nicotinate, beta-pyridylcarbinol or Pirozadil (bis-3,4,5-trimethoxybenzoate, 2,6-pyridindiyldimethylene). All 4 compounds showed a clear hypocholesterolemic and antiatherogenic effect, as measured by serum cholesterol, and by planimetric evaluation of the aortic lesions in terms of percent surface area affected in the aortas and coronary lumen. The simultaneously observed elevation of the HDL/LDL cholesterol ratio of the aortic tissue possibly indicates an antiatherogenic effect of these changes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215172     DOI: 10.1016/0021-9150(78)90134-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.

Authors:  Martina Lukasova; Camille Malaval; Andreas Gille; Jukka Kero; Stefan Offermanns
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

2.  Erythrocyte deformability improving action of beta-pyridylcarbinol tartrate.

Authors:  T Okada; A Okamoto; K Nakamura
Journal:  Experientia       Date:  1981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.